Medicine and Dentistry
Human Respiratory Syncytial Virus
93%
Systematic Review
87%
Meta-Analysis
58%
Respiratory Tract Infection
56%
Diseases
48%
COVID-19
30%
Respiratory Syncytial Virus
24%
Low and Middle Income Countries
20%
Respiratory Syncytial Virus Infection
17%
Disease Burden
14%
Pediatrics
14%
Prevalence
12%
Cohort Effect
12%
Health Care Cost
10%
Human Immunodeficiency Virus
9%
Public Health
9%
Human Metapneumovirus
9%
Serotype
9%
Virus
9%
Hypoxemia
9%
Odds Ratio
9%
Wheeze
9%
Child Health
9%
Streptococcus pneumonia
8%
Pulse Oximetry
8%
Asthma
8%
Pneumococcal Pneumonia
8%
Pathogen
8%
Hospital Mortality
8%
Virus Surveillance
8%
Case Fatality Rate
7%
Lower Respiratory Tract Infection
7%
Lung
7%
Health Survey
7%
Integrated Management of Childhood Illness
7%
Intensive Care Unit
7%
Infection
6%
Monoclonal Antibody
6%
Influenza Virus
6%
Coughing
6%
Health Care Personnel
6%
Oxygen Therapy
5%
Diarrhea
5%
Bronchiolitis
5%
Reproductive Public Health
5%
Childhood Mortality
5%
Pediatric Pneumonia
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Outpatient
5%
Respiratory Syncytial Virus Vaccine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
97%
Respiratory Tract Infection
68%
Diseases
61%
Prevalence
14%
Respiratory Syncytial Virus Infection
14%
Streptococcus pneumonia
9%
SARS Coronavirus
9%
Infection
9%
Pandemic
8%
Infectious Agent
8%
Monoclonal Antibody
7%
Chronic Obstructive Lung Disease
6%
Case Fatality Rate
6%
Comorbidity
6%
Lower Respiratory Tract Infection
6%
HIV
6%
Global Disease Burden
6%
Seasonal Influenza
6%
Hypoxemia
6%
Cohort Study
6%
Influenza Virus
5%
Prematurity
5%
Childhood Mortality
5%
Paramyxovirinae
5%
Respiratory Virus
5%
Human metapneumovirus
5%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Infection
47%
Respiratory Syncytial Virus
20%
Respiratory Syncytial Virus Infection
19%
Influenza
18%
Disease Burden
13%
Virus
11%
Serotype
10%
COVID-19
9%
Respiratory Virus
7%
Virus Surveillance
7%
Monoclonal Antibody
7%
Cohort Effect
6%
Infectious Agent
6%
Respiratory Syncytial Virus Vaccine
6%
Lower Respiratory Tract
6%
Streptococcus pneumonia
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Human Respiratory Syncytial Virus A
5%